Deepinder Goyal, one of India’s most admired self-made entrepreneurs and the visionary behind the launch of the first-of-its-kind online food delivery in India, has, in a dramatic new move, announced the launch of Continue Research. This project is the official start of Goyal’s into the booming life sciences and human longevity industry, a cause that he is contributing to with a massive $25 million personal investment in scientific discovery. Continue Research is intended to be a booster to breakthrough research to change the way humans age and live radically. The announcement establishes Goyal, who remains the Founder and CEO of Eternal (once Zomato), as an important individual contributor to the international campaign to discover the mysteries of the lifespan of human beings.

Launch and scientific mission

The introduction of the Continue Fund, a $25 million initiative, is a sign of his deeply personal investment in scientific development, since it is entirely invested in his own funds. This design is planned, as it places the initiative outside of the traditional systems of a standard company or a startup. Continue Research is meant to be a scientific project, a research community, and a seed fund of what Goyal calls the next stage of human existence.

The $25 million fund is specifically aimed at supporting scientists around the world who are ready to break with conventional paradigms and take a rigorous and systems-level approach to biology. This is a non-commercial form of funding that lacks the commercial pressures that commonly accompany venture capital and allows researchers the freedom to undertake complex, high-risk, and possibly high-reward scientific investigations. Goyal appeals to his own wealth to emphasize his belief that longevity breakthroughs need committed, long-term, and uncompromised investment.

Continue Research’s scientific mission is specialized and targeted at questioning the basic knowledge of biology. The initiative was not an overnight invention, but this was first established two years ago as an independent project to investigate upstream biological processes. These processes are believed to be the key leverage points in human biology where even minor and specific interventions would have a significant impact on the mechanisms of human aging and lifespan.

The Continue Research team is also working on an essential hypothesis of human aging. The possible confirmation of this hypothesis can redefine the existing biological concepts of longevity. The initiative will focus on the causes of aging at their core by addressing these upstream questions and not treating the symptoms that come downstream. The work is essentially aimed at mapping and shaping the simplest of biological activities that determine the speed and nature of human existence.

Open-source research and entrepreneurial legacy

One of the features of Continue Research is the ethical desire to make access universal, which is indicative of Goyal’s firm conviction in accessible science. The focus of the initiative is to find the interventions that will be helpful to the whole population and so the longevity breakthroughs will not be confined to the rich elite. This social requirement makes sure that the research to be done is targeted at the public good.

Continue Research has promised to publish all results of the core team and its sponsored partners as open-source research within the next few weeks to ensure that it can have the largest possible worldwide effect and can act in line with this principle of accessibility. It is an open format enabling the world scientific community to build on the findings without proprietary claims on the findings, spurring the rate at which human longevity is researched globally and a collaborative paradigm of complex science.

Continue Research is another addition to the illustrious career of Deepinder Goyal, who is already credited with having been the pioneer in providing the digital economy of India. In 2008, Goyal co-founded Zomato, and this initiative defined the online food delivery business in India. During his tenure, Zomato became the desired unicorn, and in 2021, it was the first Indian tech startup to reach a successful IPO, a milestone that catapulted a wave of IPOs of digital-native Indian companies.

His organization, Eternal (the new name of Zomato), is the largest new-age tech company in India in terms of market capitalization, and it is the first digital-native company to enter the exclusive club of listed companies in the BSE Sensex 30-share index. In addition to his core company, Goyal has already proven himself to be an ecosystem builder, investing in and advising more than 25 high-potential startups in various industries, such as health-tech, fintech, logistics, and consumer brands.

Conclusion

The decision to establish Continue Research by Deepinder Goyal, a $25 million personal investment, is a potent pivot of the Indian business giant, who is no longer pursuing the goal of understanding consumer technology and reallocating his strategy to the most complicated biological problem facing humanity. Goyal is leading a new model of philanthropic scientific work through organizing Continue Research as a strictly independent, personally funded group, and agreeing to open-source all its discoveries. It is not only an investment but a personal mission to get to the mechanism of human aging, and the specific aim of the project is to provide groundbreaking, affordable interventions that may redefine human lifespan across those populations around the globe.